Our guide to the issues likely to impact businesses and the key measures taken by African governments in response to COVID-19.
Our life sciences lawyers have legal, scientific and medical knowledge and understand the complexity of the business and regulatory environments in which our clients operate.
The challenges facing today’s biotechnology and medical device companies are greater than ever. For companies to take promising therapies from the laboratory to the market, they must protect those therapies from IP, regulatory and reputational risks.
We combine subject matter experience with considerable knowledge of the sector, including the scientific, medical, regulatory, commercial and enforcement environments facing our biopharmaceutical, medical device and diagnostics clients.
Experience has included advising:
- An international pharmaceutical company, in conducting a legal due diligence prior to the acquisition of 3 pharmacies in Burundi.
- A local pharmacy in conducting a legal due diligence prior to the acquisition of pharmacies in Burundi.
- A leading hospital and Swiss clinic in resolving an employment dispute.
DLA Piper Africa achieves impressive results in the newly released 2020 edition of The Legal 500: Europe, Middle East & Africa (EMEA)edition